Canary Rx Inc. (“Canary”), is thrilled to announce our partnership with Serious Seeds B.V. (“Serious Seeds”). Serious Seeds is a world renowned and...
Canary Rx Inc. Provides an Update on Construction at 44,000 Square Foot Norfolk County Cannabis Cultivation Facility Canary Rx Inc. (“Canary”) (the “Company”)...
Target Group Inc. (“Target” or the “Company”) (OTC: CBDY) announced today its Common shares have been upgraded to a listing on the OTCQB...
Effective August 2, 2018, Target Group Inc. (CBDY) completed the acquisition of all of the issued and outstanding common stock of Visava Inc. (“Visava”)....
Late stage ACMPR Applicant, Canary, receives ‘Letter of Readiness’ from Health Canada Canary Rx Inc. (“Canary”) is pleased to announce that it has...
Canary’s Intuitive, Systematic, Record Keeping Platform One of the key requirements of the Access to Cannabis for Medical Purposes Regulations (ACMPR) is that...
Health Canada Notifies Canary of Active Review Status Canary Rx Inc. (“Canary”) is pleased to announce that its application to become a licensed...
Canary is Dropping the RX, and Adopting a Sleek New Look to Prepare for Licensing Canary is delighted to officially unveil our company-wide...